Synthetic Biologics, Intrexon begin mAb therapy development for whooping cough
To manage the rising number of pertussis cases, Synthetic Biologics intends to decrease the mortality rate in infants as well as to decrease the chronic cough in adults
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.
Under the agreement, Arrowhead will receive research funding and could be eligible for development, regulatory and commercialization milestone payments of approximately $32.8m for each development candidate, an additional